ATE284688T1 - Feromone enthaltende zusammensetzung zur minderung von stress, angst und streitsucht in schweine - Google Patents

Feromone enthaltende zusammensetzung zur minderung von stress, angst und streitsucht in schweine

Info

Publication number
ATE284688T1
ATE284688T1 AT99903663T AT99903663T ATE284688T1 AT E284688 T1 ATE284688 T1 AT E284688T1 AT 99903663 T AT99903663 T AT 99903663T AT 99903663 T AT99903663 T AT 99903663T AT E284688 T1 ATE284688 T1 AT E284688T1
Authority
AT
Austria
Prior art keywords
anxiety
feromones
contradiction
pigs
composition containing
Prior art date
Application number
AT99903663T
Other languages
English (en)
Inventor
Patrick Pageat
Original Assignee
Fideline
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=31950877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE284688(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fideline filed Critical Fideline
Application granted granted Critical
Publication of ATE284688T1 publication Critical patent/ATE284688T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Compounds Of Iron (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Inorganic Insulating Materials (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT99903663T 1998-01-21 1999-01-21 Feromone enthaltende zusammensetzung zur minderung von stress, angst und streitsucht in schweine ATE284688T1 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
NO980282A NO308197B1 (no) 1998-01-21 1998-01-21 Sammensetning og oppløsning derav for Õ minske stress, angst og agressivitet hos pattedyr inneholdende en blanding av fettsyrer eller derivater derav
CA2227706A CA2227706C (en) 1998-01-21 1998-01-21 Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
JP00980298A JP4750232B2 (ja) 1998-01-21 1998-01-21 ストレス、不安および攻撃性を低減するブタ鎮静フェロモン
US09/010,515 US6077867A (en) 1998-01-21 1998-01-21 Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
EP98400117A EP0948963B1 (de) 1998-01-21 1998-01-21 Pheromone enthaltende Zusammensetzung zur Minderung von Stress, Angst und Streitsucht in Schweinen
CZ20002700A CZ20002700A3 (cs) 1998-01-21 1999-01-21 Uklidňující feromonové prostředky pro snížení stresu, úzkosti a agresivity prasat
PCT/EP1999/000375 WO1999037297A1 (en) 1998-01-21 1999-01-21 Pig appeasing pheromones to decrease stress, anxiety and aggressiveness

Publications (1)

Publication Number Publication Date
ATE284688T1 true ATE284688T1 (de) 2005-01-15

Family

ID=31950877

Family Applications (2)

Application Number Title Priority Date Filing Date
AT98400117T ATE239464T1 (de) 1998-01-21 1998-01-21 Pheromone enthaltende zusammensetzung zur minderung von stress, angst und streitsucht in schweinen
AT99903663T ATE284688T1 (de) 1998-01-21 1999-01-21 Feromone enthaltende zusammensetzung zur minderung von stress, angst und streitsucht in schweine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT98400117T ATE239464T1 (de) 1998-01-21 1998-01-21 Pheromone enthaltende zusammensetzung zur minderung von stress, angst und streitsucht in schweinen

Country Status (21)

Country Link
US (2) US6077867A (de)
EP (2) EP0948963B1 (de)
JP (1) JP4750232B2 (de)
CN (1) CN1217659C (de)
AT (2) ATE239464T1 (de)
AU (1) AU760614B2 (de)
BR (1) BRPI9907151C1 (de)
CA (2) CA2227706C (de)
CZ (1) CZ20002700A3 (de)
DE (2) DE69814343T2 (de)
DK (2) DK0948963T3 (de)
ES (2) ES2198661T3 (de)
HU (1) HU226882B1 (de)
IL (1) IL137257A0 (de)
NO (2) NO308197B1 (de)
NZ (1) NZ505813A (de)
PL (1) PL199144B1 (de)
PT (2) PT948963E (de)
SK (1) SK285905B6 (de)
WO (1) WO1999037297A1 (de)
ZA (1) ZA99426B (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323237B1 (en) * 1997-03-17 2001-11-27 Btg International Limited Therapeutic compositions
US20090253781A1 (en) * 2002-05-24 2009-10-08 Btg International Limited Therapeutic compositions
BR9917806B1 (pt) * 1998-01-21 2013-06-18 composiÇço de feromona para tratamento de estresse ou ansiedade em mamÍferos, e soluÇço.
US6054481A (en) * 1998-01-21 2000-04-25 Fideline Pig appeasing pheromones for enhancing weight gain in a mammal
EP1220669A4 (de) * 1999-10-13 2004-12-08 Marco A Chacon THERAPEUTISCHE MASSNAHME, UM DEN EFFEKT EINER KALORIENBESCHRäNKUNG NACHZUAHMEN
CA2415927C (en) * 2000-07-14 2011-08-30 Francois Couzy Dietary lipids for improving skin and coat of pets
FR2815227B1 (fr) * 2000-10-17 2003-04-11 Schwartz Laboratoires Robert Composition anti-stress destinee a etre incorporee principalement a des vehicules nutritionnels
ES2186576B1 (es) * 2001-10-11 2004-09-16 Universitat De Les Illes Balears Acido 2-hidroxioleico para utilizar como medicamento.
WO2004000336A1 (en) * 2002-06-19 2003-12-31 Fideline Avian appeasing pheromones to decrease stress, anxiety and aggressiveness
DE60332635D1 (de) 2002-06-19 2010-07-01 Fideline Le Rieu Neuf Beruhigende vogel-pheromone zur verminderung von stress, angst und aggressivität
KR100700884B1 (ko) 2002-11-14 2007-03-29 백융기 약학적으로 유용한 노화 및 스트레스 조절용 신규 페로몬 화합물 및 그 분리정제방법
GB0420856D0 (en) * 2004-09-20 2004-10-20 Ketocytonyx Inc Cns modulators
EP1766014A4 (de) 2004-06-03 2008-12-10 Athlomics Pty Ltd Mittel und verfahren zur diagnose von stress
WO2006020137A2 (en) * 2004-07-16 2006-02-23 Ketocytonyx Inc. Oligomeric compounds
EP1778615A4 (de) * 2004-07-20 2010-01-06 Btg Int Ltd Oligomere ketonverbindungen
WO2006012490A2 (en) * 2004-07-23 2006-02-02 Ketocytonyx Inc. Ketogenic saccharides
US20070197645A1 (en) * 2004-09-21 2007-08-23 Martin Keith F Treatment of adhd
WO2006034361A2 (en) * 2004-09-21 2006-03-30 Ketocytonyx Inc. Dopaminergic mimetics
US20090275670A1 (en) * 2008-04-30 2009-11-05 Marshall Gerald L Dog pheromone formulation and delivery system
FR2931676B1 (fr) * 2008-05-30 2011-01-14 Ceva Sante Animale Nouveaux modes d'administration d'un melange d'acides gras pour le traitement de mammiferes non humains
MX2011002895A (es) 2008-09-18 2011-04-11 Janssen Pharmaceutica Nv Uso de azaperona para reducir el uso de antibioticos.
WO2010044648A1 (es) 2008-10-16 2010-04-22 Ragasa Industrias S.A. De C.V. Aceite vegetal de alta pureza dieléctrico, método para obtención y su aplicación en un aparato eléctrico
US9750903B2 (en) * 2008-12-30 2017-09-05 Gearbox, Llc Method for administering an inhalable compound
US8871190B2 (en) 2009-04-25 2014-10-28 Sergeant's Pet Care Products, Inc. Polymeric pheromone formulation and method of use to calm stress-related behavior in mammals over an extended period of time
AU2010339727A1 (en) 2009-12-21 2012-08-02 Sergeant's Pet Care Products, Inc. Pheromone compositions and methods of use
CN103126886A (zh) * 2011-05-13 2013-06-05 中国农业科学院北京畜牧兽医研究所 一种仔猪安抚剂释放盒
CN102240279B (zh) * 2011-05-13 2013-04-10 中国农业科学院北京畜牧兽医研究所 一种仔猪安抚剂及其制备方法和应用
US9480688B2 (en) 2011-09-20 2016-11-01 Sergeant's Pet Care Products, Inc. Pheromone compositions and their use to modify behavior in different vertebrate species
AU2012312327B2 (en) * 2011-09-20 2016-05-26 Sergeant's Pet Care Products, Inc. Interomone compositions and their use to modify behavior in different vertebrate species
US9314018B2 (en) 2012-06-25 2016-04-19 Institut de Recherche en Semiochimie et Ethologie Appliquee Feline scratch marking semiochemicals
DK3119198T3 (da) * 2014-03-18 2020-07-13 Institut De Rech En Semiochimie Et Ethologie Appliquee Semiokemiske sammensætninger til at reducere sociale konflikter med katte
LT3119410T (lt) * 2014-03-18 2022-08-25 Institut de Recherche en Semiochimie et Ethologie Appliquée Raminamasis feromonas katėms
EP2926809A1 (de) 2014-03-31 2015-10-07 Ceva Sante Animale Zusammensetzungen auf Pheromonbasis zur Behandlung von stressbedingten Verhaltensproblemen oder medizinischen Problemen von nicht-humanen Säugetieren
FR3031039B1 (fr) * 2014-12-24 2018-03-02 Virbac Composition apaisante pour animaux comprenant au moins un acide gras et de la nepetalactone
FR3031104B1 (fr) 2014-12-26 2017-01-06 Melchior Material & Life Science France Composition pro-pheromonale apaisante pour les mammiferes
WO2016115607A1 (en) 2015-01-23 2016-07-28 Pork Crc Ltd Product and method for providing enrichment and facilitating expression of natural behaviours in pigs
JP6669761B2 (ja) * 2015-02-20 2020-03-18 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 不安神経症を治療するための中鎖脂肪酸及びそれらのトリグリセリド
EP3124020A1 (de) 2015-07-31 2017-02-01 Ceva Sante Animale Pheromonzusammensetzungen und verwendungen davon
FR3046334B1 (fr) 2015-12-31 2020-03-06 Melchior Material And Life Science France Composition solide pour le relargage controle de substances semiochimiques
AU2018354090B2 (en) 2017-10-23 2024-10-24 Epitracker, Inc. Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome
KR101994338B1 (ko) * 2017-10-25 2019-06-28 엘지이노텍 주식회사 사육장 관리 장치 및 방법
US11529418B2 (en) 2017-12-22 2022-12-20 Ceva Sante Animale Temperature-controlled semiochemical composition diffusers
EP3796976A4 (de) 2018-05-23 2022-03-30 Epitracker, Inc. Zusammensetzungen und verfahren zur diagnose und behandlung von alterungs- und langlebigen bedingungen
EP3908374A4 (de) 2019-01-09 2022-12-28 Epitracker, Inc. Zusammensetzungen und verfahren zur diagnose und behandlung von neurodegenerativen erkrankungen
JP7404382B2 (ja) 2019-03-04 2023-12-25 エピトラッカー インコーポレイテッド 脂肪酸アナログ、ならびに認知機能障害、行動症状および慢性疼痛の処置におけるそれらの使用
BR112022004898A2 (pt) 2019-09-19 2022-06-07 J Mcglone John Feromônio neonatal materno de suíno
KR20220143681A (ko) 2020-02-19 2022-10-25 마렐 미트 에이/에스 동물들을 예비-기절 및/또는 기절시키기 위한 방법 및 시스템
AU2021329909A1 (en) * 2020-08-20 2023-03-09 Epitracker, Inc. Compositions and methods for mood enhancement
CN117083062A (zh) * 2020-10-19 2023-11-17 第二基因组公司 用于治疗孤独症谱系障碍的方法
CN112370528B (zh) * 2020-10-23 2022-04-08 宁波三生生物科技股份有限公司 一种具标识功能的信息素组合物及其制剂
JP2024539823A (ja) 2021-11-03 2024-10-31 エピトラッカー インコーポレイテッド 老化の質および寿命に関係する状態の治療のためのペンタデカノイルカルニチン
CN114452238B (zh) * 2022-01-07 2023-10-27 佛山市南海东方澳龙制药有限公司 具有安抚作用的宠物药浴香波及其制备方法
BR112023010845A2 (pt) * 2022-03-14 2023-10-24 Fera Diagnostics And Biologicals Corp Composições de ácido graxo e métodos
CN117322521A (zh) * 2023-10-20 2024-01-02 中国农业大学 十五烷酸在缓解动物断奶应激中的应用
CN117919345B (zh) * 2023-12-21 2026-07-21 宁波三生生物科技股份有限公司 一种信息素组合物及其制备方法
EP4595749A1 (de) 2024-02-02 2025-08-06 Signs Verfahren zur freisetzung eines semiochemischen stoffes in der umgebung durch passive diffusion, system und mittel, insbesondere stifte, an diesem ende und verwendungen davon
CN120938981A (zh) * 2025-10-20 2025-11-14 宁波三生生物科技股份有限公司 一种信息素组合物及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61249371A (ja) * 1985-04-30 1986-11-06 Nippon Oil & Fats Co Ltd 栄養飲料組成物
JP3039817B2 (ja) * 1990-09-28 2000-05-08 株式会社資生堂 シャンプー組成物
ES2034888B1 (es) * 1991-07-11 1994-02-16 Madaus Cerafarm Lab Procedimiento de obtencion de la fraccion acida total de los extractos lipidicos de los frutos del sabal serrulata.
US5425963A (en) * 1991-09-17 1995-06-20 Church & Dwight Co., Inc. High purity fatty acid salt products
WO1993011987A1 (fr) * 1991-12-13 1993-06-24 Viktor Nikolaevich Kizilov Vehicule sur coussin d'air
SE9200541D0 (sv) * 1992-02-24 1992-02-24 Kabi Pharmacia Ab New usee of omega-3-fatty acids
WO1993018667A1 (en) * 1992-03-20 1993-09-30 Church & Dwight Company, Inc. Encapsulated dietary fatty acid salt products
CA2151820C (en) * 1993-01-15 2000-11-28 Stephen Joseph Demichele Structured lipids
DK0724832T3 (da) * 1995-02-03 2000-04-10 Fideline Egenskaber ved kattes faciale feromoner
DE19511572C2 (de) * 1995-03-29 1998-02-26 Henkel Kgaa Niedrigviskose Trübungsmittelkonzentrate
DE19615777C2 (de) * 1996-04-20 1999-04-01 Henkel Kgaa Verwendung von Milchsäure-Milchsäureester-Mischungen
BR9917806B1 (pt) * 1998-01-21 2013-06-18 composiÇço de feromona para tratamento de estresse ou ansiedade em mamÍferos, e soluÇço.

Also Published As

Publication number Publication date
CN1291093A (zh) 2001-04-11
JPH11209293A (ja) 1999-08-03
BRPI9907151B1 (pt) 2016-02-16
NO329205B1 (no) 2010-09-13
DE69922633D1 (de) 2005-01-20
PL341867A1 (en) 2001-05-07
HUP0101312A2 (hu) 2001-08-28
DE69814343D1 (de) 2003-06-12
ES2198661T3 (es) 2004-02-01
CN1217659C (zh) 2005-09-07
AU2423799A (en) 1999-08-09
HUP0101312A3 (en) 2005-11-28
NO980282L (no) 1999-07-22
EP1047415A1 (de) 2000-11-02
ZA99426B (en) 1999-07-21
CA2318392A1 (en) 1999-07-29
DK0948963T3 (da) 2003-08-11
EP1047415B1 (de) 2004-12-15
US6384252B1 (en) 2002-05-07
ATE239464T1 (de) 2003-05-15
HU226882B1 (en) 2010-01-28
DK1047415T3 (da) 2005-04-25
NO980282D0 (no) 1998-01-21
BR9907151A (pt) 2000-10-24
ES2234236T3 (es) 2005-06-16
BRPI9907151B8 (pt) 2017-11-14
NO308197B1 (no) 2000-08-14
IL137257A0 (en) 2001-07-24
CA2227706A1 (en) 1999-07-21
PT948963E (pt) 2003-09-30
JP4750232B2 (ja) 2011-08-17
DE69814343T2 (de) 2003-12-24
US6077867A (en) 2000-06-20
WO1999037297A1 (en) 1999-07-29
CZ20002700A3 (cs) 2000-12-13
SK285905B6 (sk) 2007-10-04
PT1047415E (pt) 2005-04-29
PL199144B1 (pl) 2008-08-29
NO20003693D0 (no) 2000-07-19
DE69922633T2 (de) 2005-12-15
CA2318392C (en) 2011-11-15
EP0948963B1 (de) 2003-05-07
NO20003693L (no) 2000-09-20
SK10902000A3 (sk) 2001-02-12
NZ505813A (en) 2003-07-25
BRPI9907151C1 (pt) 2021-05-25
CA2227706C (en) 2010-08-03
AU760614B2 (en) 2003-05-22
EP0948963A1 (de) 1999-10-13

Similar Documents

Publication Publication Date Title
DE69922633D1 (de) Feromone enthaltende zusammensetzung zur minderung von stress, angst und streitsucht in schweine
ES2127022T3 (es) Aditivos y composiciones de fueloleo.
DE69534801D1 (de) Neues lysin decarboxylase gen und verfahren zur herstellung von l-lysin
ES2131878T3 (es) Esteres sinteticos de alcoholes y de mezclas de acidos grasos procedentes de aceites vegetales ricos en acido oleico, pobres en acido estearico.
DE59808772D1 (de) Verwendung synthetischer Triglyceride auf Basis konjugierter Linolsäure zur Herstellung von Mitteln zur Unterstützung der Tumorbehandlung
FR2800608B1 (fr) Composition cosmetique contenant un ester d'acide gras hydroxyle
ATE109821T1 (de) Verfahren zur fraktionierung einer fettsäuremischung.
ATE221319T1 (de) Essbare, pflanzliches fett enthaltende zusammensetzung
DE69530403D1 (de) Analogen des keratinozytenwachstumfaktors
DE69031732D1 (de) Verfahren zur herstellung von glykosid-estern und zusammensetzungen daraus
ES2118629T3 (es) Mezcla de grasas conteniendo fosfolipidos con acidos grasos lcp
ATE422216T1 (de) Mediumzusätze und medien für tierzellkulturen
DE69811676D1 (de) Verfahren zur verminderung des gehaltes an langkettigen gesättigten fettsäuren in fettsäurezusammensetzungen
ATE52025T1 (de) Fettzusammensetzung pflanzlichen ursprungs zur kosmetischen verwendung.
FR2604624B1 (fr) Nouvelles compositions cosmetiques ou dermatologiques riches en acides gras essentiels presents a la fois sous forme de triglycerides et sous forme libre ou salifiee
ATE228556T1 (de) An omega-3 ungesättigten fettsäuren angereicherte wachsester, ihre herstellung und verwendung
ATE465158T1 (de) Anwendungen von tocopherolestern
GR3006279T3 (de)
DE59803054D1 (de) Verfahren zur Herstellung von hellfarbigen Fettsäureniedrigalkylestern mit vermindertem Gehalt an freiem und gebundenem Glycerin
EA199900570A1 (ru) Гипоталамо-гипофизарное средство, вызывающее устойчивую стадию торможения и/или покоя у собак и стадию покоя у кошек (анэструс)
UA33167A (uk) Комбінована мазь для лікування ран "мазь фенітол"

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1047415

Country of ref document: EP